Head and neck cancer

Experimental Metastasis: Modeling and Analysis

Volumn , Issue , 2013, Pages 7-26

  Gilbert, Mark R ^a   Lim, Chwee Ming ^b   Kim, Seungwon ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956535658     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-7835-1_2     Document Type: Chapter

References (94)

1. Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R et al (2010) SEER Cancer Statistics Review, 1975-2007. http://seer.cancer.gov/csr/1975_2007/: based on November 2009 SEER data submission, posted to the SEER web site
2. Davies L, Welch HG (2006) Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 135:451-457
3. Garavello W, Ciardo A, Spreafico R, Gaini RM (2006) Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132:762-766
4. Becker MT, Shores CG, Yu KK, Yarbrough WG (2004) Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:21-27
5. Vermorken JB, Specenier P (2010) Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol 21(Suppl 7):vii252-261
6. Howell GM, Grandis JR (2005) Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 27:710-717
7. Andrews NA, Jones AS, Helliwell TR, Kinsella AR (1997) Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 75:1474-1480
8. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118-132
9. Ikebe T, Shinohara M, Takeuchi H, Beppu M, Kurahara S et al (1999) Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17:315-323
10. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M et al (1999) Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21:627-638
11. Rodrigo JP, Dominguez F, Alvarez C, Manrique C, Herrero A et al (2002) Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinico-pathological features. Eur J Cancer 38:1059-1064
12. Sato H, Takino T, Okada Y, Cao J, Shinagawa A et al (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65
13. Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M et al (2004) Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol 12:323-328
14. Muramatsu H, Akimoto T, Maebayashi K, Kita M, Mitsuhashi N (2008) Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy. Anticancer Res 28:3859-3864
15. Kudo Y, Ogawa I, Kitajima S, Kitagawa M, Kawai H et al (2006) Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66:6928-6935
16. Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M et al (2000) Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 31:895-904
17. Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL et al (2002) A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 95:1663-1672
18. Deraz EM, Kudo Y, Yoshida M, Obayashi M, Tsunematsu T et al (2011) MMP-10/stromely-sin-2 promotes invasion of head and neck cancer. PLoS One 6:e25438
19. Christopoulos A, Ahn SM, Klein JD, Kim S (2011) Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis. Head Neck 33:1220-1229
20. Shemirani B, Crowe DL (2000) Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors. Oral Oncol 36:61-66
21. Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18:2046-2052
22. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676
23. Bock JM, Sinclair LL, Bedford NS, Jackson RE, Lee JH et al (2008) Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 134:355-362
24. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG et al (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15:232-239
25. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220-231
26. Bhaijee F, Pepper DJ, Pitman KT, Bell D (2011) Cancer stem cells in head and neck squamous cell carcinoma: A review of current knowledge and future applications. Head Neck 34(6):894-899
27. Shen R, Ye Y, Chen L, Yan Q, Barsky SH et al (2008) Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One 3:e1652
28. Sayed SI, Dwivedi RC, Katna R, Garg A, Pathak KA et al (2011) Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol 47:237-243
29. Fidler IJ (1986) Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5:29-49
30. Killion JJ, Radinsky R, Fidler IJ (1998) Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17:279-284
31. Kubota T (1994) Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem 56:4-8
32. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR et al (1994) Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am J Pathol 145:365-374
33. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z et al (1994) Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 13:209-222
34. Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD et al (1994) Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 86:913-920
35. Radinsky R, Beltran PJ, Tsan R, Zhang R, Cone RD et al (1995) Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma. Cancer Res 55:141-148
36. Salley JJ (1954) Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res 33:253-262
37. Lin LM, Chen YK, Lai DL, Huang YL (1996) Minimal arecaidine concentrations showing a promotion effect during DMBA-induced hamster cheek pouch carcinogenesis. J Oral Pathol Med 25:65-68
38. Kim TW, Chen Q, Shen X, Regezi JA, Ramos DM et al (2002) Oral mucosal carcinogenesis in SENCAR mice. Anticancer Res 22:2733-2740
39. Wong DT, Gallagher GT, Gertz R, Chang AL, Shklar G (1988) Transforming growth factor alpha in chemically transformed hamster oral keratinocytes. Cancer Res 48:3130-3134
40. Schwartz JL, Shklar G (1996) Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis. Nutr Cancer 26:229-236
41. Gimenez-Conti IB, Bianchi AB, Stockman SL, Conti CJ, Slaga TJ (1992) Activating mutation of the Ha-ras gene in chemically induced tumors of the hamster cheek pouch. Mol Carcinog 5:25-263
42. Robles AI, Gimenez-Conti IB, Roop D, Slaga TJ, Conti CJ (1993) Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz[a]-anthracene-induced hamster skin tumors. Mol Carcinog 7:94-98.
43. Schwartz JL, Antoniades DZ, Zhao S (1993) Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Ann N Y Acad Sci 686:262-278; discussion 278-269
44. Wallenius K, Lekholm U (1973) Oral cancer in rats induced by the water-soluble carcinogen 4-nitrochinoline N-oxide. Odontol Revy 24:39-48
45. Yuan B, Heniford BW, Ackermann DM, Hawkins BL, Hendler FJ (1994) Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Cancer Res 54:5310-5317
46. Osugi Y (1996) p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue. J Osaka Dent Univ 30:29-35
47. Sakaki T, Tamura I, Kadota H, Kakudo K (2003) Changing expression of E- and P-cadherin during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. J Oral Pathol Med 32:530-537
48. Nishimura A (1999) Changes in Bcl-2 and Bax expression in rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. J Dent Res 78:1264-1269
49. Nauta JM, Roodenburg JL, Nikkels PG, Witjes MJ, Vermey A (1995) Comparison of epithelial dysplasia-the 4NQO rat palate model and human oral mucosa. Int J Oral Maxillofac Surg 24:53-58
50. Fitch KA, Somers KD, Schechter GL (1988) The development of a head and neck tumor model in the nude mouse. In: Wolf GT, Carey TE (eds) Head and neck oncology research. Kugler & Ghedini, Amsterdam (Distributors for the U.S.A. and Canada, Kugler Publications). pp. 187-190
51. Dinesman A, Haughey B, Gates GA, Aufdemorte T, Von Hoff DD (1990) Development of a new in vivo model for head and neck cancer. Otolaryngol Head Neck Surg 103:766-774
52. Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ (2002) An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 8:293-298
53. Cabanillas R, Secades P, Rodrigo JP, Astudillo A, Suarez C et al (2005) [Orthotopic murine model of head and neck squamous cell carcinoma]. Acta otorrinolaringologica espanola 56:89-95
54. Bao A, Phillips WT, Goins B, McGuff HS, Zheng X et al (2006) Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats. Otolaryngol Head Neck 135:853-857
55. Jetten AM, Kim JS, Sacks PG, Rearick JI, Lotan D et al (1990) Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid. Int J Cancer 45:195-202
56. Heo DS, Snyderman C, Gollin SM, Pan S, Walker E et al (1989) Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 49:5167-5175
57. Matijevic T, Marjanovic M, Pavelic J (2009) Functionally active toll-like receptor 3 on human primary and metastatic cancer cells. Scand J Immunol 70:18-24
58. Jimeno A, Kulesza P, Wheelhouse J, Chan A, Zhang X et al (2007) Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy. British J Cancer 96:952-959
59. Patel V, Marsh CA, Dorsam RT, Mikelis CM, Masedunskas A et al (2011) Decreased lymphan-giogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res71:7103-7112
60. O’Malley BW Jr., Cope KA, Johnson CS, Schwartz MR (1997) A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg 123:20-24
61. Cui N, Nomura T, Noma H, Yokoo K, Takagi R et al (2005) Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice. Clin Cancer Res 11:2713-2719
62. Behren A, Kamenisch Y, Muehlen S, Flechtenmacher C, Haberkorn U et al (2010) Development of an oral cancer recurrence mouse model after surgical resection. Int J Oncol 36:849-855
63. Yu Z, Li S, Huang YY, Lin SF, Fong Y et al (2008) Sensitivity of squamous cell carcinoma lymph node metastases to herpes oncolytic therapy. Clin Cancer Res 14:1897-1904
64. Matsumoto G, Yajima N, Saito H, Nakagami H, Omi Y et al (2010) Cold shock domain protein A (CSDA) overexpression inhibits tumor growth and lymph node metastasis in a mouse model of squamous cell carcinoma. Clin Exp Metastasis 27:539-547
65. Judd NR Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH et al (2012) ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness. Cancer Res 72:365-374
66. Caulin C, Nguyen T, Longley MA, Zhou Z, Wang XJ et al (2004) Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res 64:5054-5058
67. Vitale-Cross L, Amornphimoltham R Fisher G, Molinolo AA, Gutkind JS (2004) Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 64:8804-8807
68. Raimondi AR, Molinolo A, Gutkind JS (2009) Rapamycin prevents early onset of tumorigen-esis in an oral-specific K-ras and p53 two-hit carcinogenesis model. Cancer Res 69:4159-4166
69. Moral M, Segrelles C, Lara MF, Martinez-Cruz AB, Lorz C et al (2009) Akt activation syn-ergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma. Cancer Res 69:1099-1108
70. Saranath D, Chang SE, Bhoite LT, Panchal RG, Kerr IB et al (1991) High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 63:573-578
71. Munirajan AK, Mohanprasad BK, Shanmugam G, Tsuchida N (1998) Detection of a rare point mutation at codon 59 and relatively high incidence of H-ras mutation in Indian oral cancer. Int J Oncol 13:971-974
72. Kuriakose MA, Trivedi NP (2009) Sentinel node biopsy in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 17:100-110
73. Stoeckli SJ, Alkureishi LW, Ross GL (2009) Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 266:787-793
74. Jefferson GD, Sollaccio D, Gomez-Fernandez CR, Civantos F Jr. (2011) Evaluation of immu-nohistochemical fine sectioning for sentinel lymph node biopsy in oral squamous cell carcinoma. Otolaryngol Head Neck Surg 144:216-219
75. Coughlin A, Resto VA (2010) Oral cavity squamous cell carcinoma and the clinically n0 neck: the past, present, and future of sentinel lymph node biopsy. Current oncology reports 12:129-135
76. Alkureishi LW, Ross GL, Shoaib T, Soutar DS, Robertson AG et al (2010) Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 17:2459-2464
77. Harrell MI, Iritani BM, Ruddell A (2008) Lymph node mapping in the mouse. J Immunol Methods 332:170-174
78. Alitalo A, Detmar M (2011) Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31(42):4499-4508
79. Bredell MG (2010) Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer—preliminary experience. Head Neck Oncol 2:31
80. Mathelin C, Croce S, Brasse D, Gairard B, Gharbi M et al (2009) Methylene blue dye, an accurate dye for sentinel lymph node identification in early breast cancer. Anticancer Res 29:4119-4125
81. Wong JH, Cagle LA, Morton DL (1991) Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 214:637-641
82. Rebhun RB, Lazar AJ, Fidler IJ, Gershenwald JE (2008) Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin Exp Metastasis 25:191-199
83. Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL et al (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66:8065-8075
84. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF et al (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196:1497-1506
85. Close DM, Xu T, Sayler GS, Ripp S (2011) In Vivo Bioluminescent Imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors (Basel) 11:180-206
86. Sano D, Fooshee DR, Zhao M, Andrews GA, Frederick MJ et al (2011) Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vande-tanib in a mouse model. Head Neck 33:349-358
87. Sano D, Matsumoto F, Valdecanas DR, Zhao M, Molkentine DP et al (2011) Vandetanib restores head and neck squamous cell carcinoma cells’ sensitivity to cisplatin and radiation in vivo and in vitro. Clin Cancer Res 17:1815-1827
88. Sano D, Choi S, Milas ZL, Zhou G, Galer CE et al (2009) The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg 135:411-420
89. Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR (2007) Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther 6:1230-1238
90. Keereweer S, Kerrebijn JD, Mol IM, Mieog JS, Van Driel PB et al (2011) Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis. Head Neck 34(7):1002-1008
91. Niu G, Li Z, Xie J, Le QT, Chen X (2009) PET of EGFR antibody distribution in head and neck squamous cell carcinoma models. J Nucl Med 50:1116-1123
92. Niu G, Sun X, Cao Q, Courter D, Koong A et al (2010) Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma. Clin Cancer Res 16:2095-2105
93. Savastano LE, Castro AE, Fitt MR, Rath MF, Romeo HE, Muñoz EM (2010) A standardized surgical technique for rat superior cervical ganglionectomy. J Neurosci Methods 192(1):22-33
94. Keereweer S, Mol IM, Vahrmeijer A, Driel PV, Baatenburg deJRJ, Kerrebijn JD, Lowik C (2011) Towards optical image-guided head and neck cancer surgery: Multi-targeted dual wavelength detection using near-infrared fluorescence probes. The fourth annual world molecular imaging congress, Scientific Session 17: Cancer Cell Detection. Presentation Number T154